Results 131 to 140 of about 2,626 (203)

Measurement of Tralokinumab Concentrations in Serum and Tear Fluid of Atopic Dermatitis Patients and the Relationship With Treatment Response and Ocular Surface Disease. [PDF]

Clin Exp Allergy
Dekkers C, Smeijsters EH, El Amrani M, Jager CDH, van der Elst KCM, van Luin M, van Luijk C, Bakker DS, Huitema ADR, de Graaf M, van Wijk F, de Bruin-Weller MS.   +11 more
europepmc   +1 more source

Real-World Clinical Practice Evaluation of Tralokinumab in Atopic Dermatitis: A 52-Week Multi-Center Retrospective Study in the Basque Country. [PDF]

J Clin Med
Izu Belloso RM, Juliá Manresa M, Martínez Peña N, Pretel Irazabal M, Fatsini Blanch V, Ormaechea Pérez N, Pascual Ares M, Ratón Nieto JA.   +7 more
europepmc   +1 more source

Novel Therapeutic Strategies for Atopic Dermatitis: Biomarker Modulation and Clinical Implications. A Systematic Review. [PDF]

Clin Rev Allergy Immunol
Moreiras-Arias N, Nieto-Fontarigo JJ, Salgado FJ, González-Vilas D, Paredes-Suárez C, Combo-García E, Rodríguez-Otero C, Flórez Á.   +7 more
europepmc   +1 more source

Long-Term Use of Tralokinumab in Patients With Atopic Dermatitis: A Real-World Multicentric Case Series. [PDF]

Int J Dermatol
Bangert C, Ebner B, Gruber B, Meyersburg D, Traxler J.   +4 more
europepmc   +1 more source

Comparative Efficacy and Safety of Tralokinumab and Dupilumab in Moderate-to-Severe Atopic Dermatitis: A Narrative Review. [PDF]

J Clin Med
Kim YS.
europepmc   +1 more source

Health care resource utilization and costs of commercially insured US patients with atopic dermatitis switching from first-line to second-line systemic targeted therapies. [PDF]

J Manag Care Spec Pharm
Li KH, Gray SL, Sullivan SD.
europepmc   +1 more source

Systemic Therapies for Moderate-to-Severe Atopic Dermatitis in Children and Adolescents: A Systematic Review. [PDF]

Cureus
Hamza Osman SK, Mohamed Ahmed MA, Idrees H, Mohammad Ali AMH, Ahmed Taha AH, Musa Shaikhelsafi FH, Mirghani Hamour AM.   +6 more
europepmc   +1 more source

Mycosis fungoides unmasked by tralokinumab treatment for atopic dermatitis

JAAD Case Reports
Sanah Basrai, BA, Alexander R. Gomez-Lara, BA, BS, Dante Dahabreh, MD, Sebastien De Feraudy, MD, PhD, Eunice Y. Tsai, MD, Patrick E. McCleskey, MD   +5 more
doaj   +1 more source

Lebrikizumab-induced psoriasis in a patient with atopic dermatitis. [PDF]

JAAD Case Rep
Cutrona M, Golant AK.
europepmc   +1 more source

Drug Survival and Predictors of Systemic Treatment Outcome in Atopic Dermatitis: Data From a Nationwide Swedish Cohort. [PDF]

Acta Derm Venereol
Jonsson PO, Tayefi M, Svedbom A, Bradley M, Johansson EK.   +4 more
europepmc   +1 more source